279 related articles for article (PubMed ID: 24021907)
21. A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.
Kampfenkel T; Baraniskin A; Teschendorf C; Schmiegel W; Massenkeil G
Acta Haematol; 2010; 124(1):57-60. PubMed ID: 20616540
[TBL] [Abstract][Full Text] [Related]
22. Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.
Ashihara N; Nakajima K; Nakamura Y; Kobayashi M; Shirahata K; Maeda C; Uehara T; Gomi D; Ito N
Intern Med; 2016; 55(23):3453-3457. PubMed ID: 27904108
[TBL] [Abstract][Full Text] [Related]
23. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.
Shivnani SB; Shelton JM; Richardson JA; Maalouf NM
Endocr Pract; 2009 Apr; 15(3):234-9. PubMed ID: 19364692
[TBL] [Abstract][Full Text] [Related]
25. Denosumab in hypercalcemia of malignancy: a case series.
Dietzek A; Connelly K; Cotugno M; Bartel S; McDonnell AM
J Oncol Pharm Pract; 2015 Apr; 21(2):143-7. PubMed ID: 24415364
[TBL] [Abstract][Full Text] [Related]
26. Hypercalcemia in patients with oral squamous cell carcinoma.
Iwase M; Kurachi Y; Kakuta S; Sakamaki H; Nakamura-Mitsuhashi M; Nagumo M
Clin Oral Investig; 2001 Sep; 5(3):194-8. PubMed ID: 11642565
[TBL] [Abstract][Full Text] [Related]
27. Denosumab for the treatment of bisphosphonate-refractory hypercalcemia.
Boikos SA; Hammers HJ
J Clin Oncol; 2012 Oct; 30(29):e299. PubMed ID: 22949145
[No Abstract] [Full Text] [Related]
28. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
29. Update on the medical treatment of hypercalcemia of malignancy.
Hall TG; Schaiff RA
Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of parathyroid hormone-related protein in a squamous cell carcinoma arising from mature cystic teratoma causing humoral hypercalcemia of malignancy.
Takeuchi K; Murata K; Funaki K; Kitazawa S; Kitazawa R
Gynecol Oncol; 2000 Dec; 79(3):504-7. PubMed ID: 11104629
[TBL] [Abstract][Full Text] [Related]
31. Control of Refractory Hypercalcemia with Denosumab in a Case of Metastatic Parathyroid Carcinoma.
Çalapkulu M; Gul OO; Cander S; Ersoy C; Erturk E; Sagiroglu MF; Saraydaroglu O
J Coll Physicians Surg Pak; 2020 Jul; 30(7):757-759. PubMed ID: 32811610
[TBL] [Abstract][Full Text] [Related]
32. [Hypercalcemia in myeloma].
Abe M
Nihon Rinsho; 2007 Dec; 65(12):2245-9. PubMed ID: 18069268
[TBL] [Abstract][Full Text] [Related]
33. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
[TBL] [Abstract][Full Text] [Related]
34. Medical treatment of malignancy-associated hypercalcemia.
Lumachi F; Brunello A; Roma A; Basso U
Curr Med Chem; 2008; 15(4):415-21. PubMed ID: 18288996
[TBL] [Abstract][Full Text] [Related]
35. [High PTHrP level induced hypercalcemia and acute renal failure in a multiple myeloma patient].
Saito O; Kurosu M; Ando Y; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):41-6. PubMed ID: 10737013
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone-related peptide mediated hypercalcaemia with squamous cell carcinoma of the anus.
Williams J; Seelamanthula V; Loon K
ANZ J Surg; 2018 May; 88(5):516-517. PubMed ID: 29752792
[No Abstract] [Full Text] [Related]
37. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
Wysolmerski JJ; Broadus AE
Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
[TBL] [Abstract][Full Text] [Related]
38. Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy.
Sheehan MT; Wermers RA; Jatoi A; Loprinzi CL; Onitilo AA
Med Hypotheses; 2020 Oct; 143():110149. PubMed ID: 32763659
[TBL] [Abstract][Full Text] [Related]
39. Hypercalcemia induced by parathyroid hormone-related peptide after treatment of carcinoma.
Gover A; Kumar PD; Brown LA; Ravakhah K
South Med J; 2002 Feb; 95(2):258-60. PubMed ID: 11846257
[TBL] [Abstract][Full Text] [Related]
40. [New development in bisphosphonate treatment. Treatment with bisphosphonates for cancer-induced bone disease].
Abe M
Clin Calcium; 2009 Jan; 19(1):55-62. PubMed ID: 19122265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]